Please login to the form below

Not currently logged in


This page shows the latest Oligomannate news and features for those working in and with pharma, biotech and healthcare.

China okays Green Valley’s algae-based drug for Alzheimer’s drug

China okays Green Valley’s algae-based drug for Alzheimer’s drug

Oligomannate is the first new drug to be approved for  Alzheimer’s since memantine, which was approved in Europe in 2002 and the US in 2003. ... Green Valley says it will launch Oligomannate in China 'very soon' while also carrying out trials to

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....